Headquarters
Paris, FranceFounded
2018CEO / Founder
Alexandre LebrunEmployees
51-200Funding
Series C — $120MProducts
1 product listedAvg. AI Score
8.0/10Website
nabla.com/Profile updated
Nabla is a health technology company that develops an ambient artificial intelligence assistant for clinicians, generating structured clinical notes and medical codes in real time from doctor-patient conversations and integrating the output into electronic health record systems. The company was founded in 2018 by Alexandre Lebrun, Delphine Groll, and Martin Raison, and is headquartered in Paris, France, with a growing presence in the United States.
The company's core product is an ambient scribe, marketed as Nabla Copilot, that listens to a consultation and drafts documentation, dictation, and coding for the clinician to review. The system integrates with major EHR platforms and supports more than 35 languages. Nabla is deployed across 190+ health organizations and used by more than 100,000 clinicians, positioning it among the more widely adopted vendors in the ambient clinical documentation market alongside competitors such as Abridge and Microsoft-owned Nuance DAX.
Nabla raised a $24 million Series B in January 2024, followed by a $70 million Series C announced in June 2025 that was led by HV Capital with participation from Highland Europe, DST Global, Cathay Innovation, and Tony Fadell's Build Collective. The Series C brought total funding to $120 million. The company employs an estimated 51 to 200 people and has used its capital to expand agentic AI features and grow its footprint in the U.S. healthcare market.
Dated, source-cited figures. Estimates are marked.
All products by Nabla reviewed by our AI panel of experts.
Six independent reviewer personalities assessed Nabla's product on their own terms. They landed within 0.9 points of each other, an unusually strong consensus.
Averaged across 1 reviewed product in our catalog. Scores are out of 10.
Who Nabla competes with, and how they differ.
Abridge is the best-funded rival in ambient clinical documentation: a $300M Series E in June 2025 valued it at $5.3B and it reported roughly $100M ARR by mid-2025, with deep Epic-native rollouts at Kaiser Permanente and Mayo Clinic outscaling Nabla's $120M raised to date.
1 product reviewed on TopReviewedAmbience raised a $243M Series C in July 2025 at a $1.25B valuation and differentiates on deep per-specialty tuning across 100+ ambulatory subspecialties plus point-of-care coding, versus Nabla's broader push into agentic, multi-step clinical workflows.
1 product reviewed on TopReviewedNuance's Dragon Ambient eXperience (DAX Copilot) is the incumbent enterprise choice, bundled into Microsoft's Azure/Epic ecosystem and backed by decades of Dragon Medical dictation relationships in hospitals - a distribution advantage independent challengers like Nabla must compete against on product rather than platform bundling.
9 products reviewed on TopReviewedSuki raised $70M in an October 2024 round and positions itself as an EHR-agnostic voice assistant that also handles orders, coding and billing tasks, competing with Nabla on breadth of clinical workflow automated beyond note generation.
1 product reviewed on TopReviewedHeidi undercuts on price with a genuinely free tier and has raised about $86.6M to date (most recently a $65M Series B in October 2025), targeting smaller practices and international markets rather than the large US/EU health-system enterprise deals Nabla pursues.
1 product reviewed on TopReviewedDeepScribe has raised roughly $60-64M, far less than Nabla's $120M, and competes on specialty-tuned models - notably oncology via its Flatiron Health partnership - sold enterprise-only at roughly $350-500+ per provider per month.
1 product reviewed on TopReviewedKey milestones in Nabla's history, with sources.
Appoints Brian Manning as CEO
Nabla named Brian Manning, previously President and Chief Revenue Officer at Bamboo Health, as Chief Executive Officer to lead its next phase of enterprise growth. Co-founder Alex Lebrun remains Executive Chairman and Chief AI Officer.
prnewswire.comExclusive partnership with Yann LeCun's Advanced Machine Intelligence; co-founder Lebrun becomes AMI CEO
Nabla announced an exclusive strategic partnership with Advanced Machine Intelligence (AMI, founded by Yann LeCun) for early access to world-model technology aimed at FDA-certifiable agentic healthcare AI. Co-founder and CEO Alex Lebrun moved to become AMI's CEO while taking the Chief AI Scientist and Chairman roles at Nabla; co-founder Delphine Groll led daily operations during the board's search for a new CEO.
nabla.comLCMC Health selects Nabla for systemwide ambient AI rollout
New Orleans-based LCMC Health, an eight-hospital system with roughly 2,800 clinicians, selected Nabla to power a systemwide ambient AI rollout integrated with its Epic EHR.
prnewswire.comStrategic partnership with Navina integrates clinical intelligence and ambient AI
Nabla and clinical-intelligence platform Navina announced a strategic partnership combining Navina's pre-visit patient-record co-pilot with Nabla's in-visit ambient documentation, aimed at value-based-care workflows.
prnewswire.comSeries C - $70M led by HV Capital, total funding reaches $120M
Nabla raised a $70M Series C led by HV Capital, with Highland Europe, DST Global and existing investors Cathay Innovation and Tony Fadell's Build Collective participating, bringing total funding to $120M. Nabla reported 85,000+ clinicians across 130+ organizations and 20M annual encounters.
prnewswire.comWomen's health provider Tia rolls out Nabla across all clinics
After a two-month pilot with 30 providers across seven specialties that cut note-submission time by 50%, women's health provider Tia expanded Nabla's ambient AI assistant to all its clinics, covering telehealth and in-person visits.
prnewswire.comJoins the Coalition for Health AI (CHAI)
Nabla joined CHAI, a private-sector coalition developing best-practice frameworks for quality assurance, fairness, transparency and safety of health AI algorithms.
prnewswire.comPartners with Carle Health for ambient AI scribe rollout
Illinois health system Carle Health rolled out Nabla's ambient AI assistant, integrated with its Epic EHR, after a four-week pilot across family medicine, pediatrics and cardiology, expanding through the year to roughly 1,500 providers.
fiercehealthcare.comSeries B - $24M led by Cathay Innovation
Nabla raised a $24M Series B led by Cathay Innovation with participation from ZEBOX Ventures, bringing total funding to over $43M; TechCrunch reported a source-cited post-money valuation near $180M.
prnewswire.comShifts Copilot from OpenAI's GPT-4 to open-source and proprietary models
Nabla moved its clinical AI stack away from OpenAI's GPT-4 toward a mix of open-source and proprietary large language and speech-to-text models built by its own former Meta AI Research engineers.
forbes.comLaunches Nabla Copilot, a GPT-3-powered ambient AI assistant for physicians
Nabla launched Copilot, a Chrome extension using GPT-3 to turn doctor-patient conversations into clinical notes, prescriptions and consultation summaries, marking its pivot away from earlier consumer health products.
techcrunch.comNabla founded in Paris by Alexandre Lebrun, Delphine Groll and Martin Raison
Alexandre Lebrun (previously co-founder of Wit.ai, acquired by Facebook, and Virtuoz, acquired by Nuance), Delphine Groll and Martin Raison founded Nabla in Paris in 2018.
prnewswire.comBrowse multi-perspective AI panel reviews across hundreds of AI tools, agents, and platforms. Find the right software with insights from CTO, Developer, Marketer, Finance, and User perspectives.